Multiple Assemblies exist for SMTL entry 4ncg
Discovery of Doravirine, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses; X-RAY DIFFRACTION 2.58 Å

	SMTL ID 4ncg.1 Ligands 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile Polypeptides Reverse transcriptase/ribonuclease H; p51 RT Oligo-state hetero-2-2-mer
	SMTL ID 4ncg.2 Ligands 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile Polypeptides Reverse transcriptase/ribonuclease H; p51 RT Oligo-state hetero-1-1-mer